相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metformin may antagonize Lin28 and/or Lin28B activity, thereby boosting let-7 levels and antagonizing cancer progression
Mark F. McCarty
MEDICAL HYPOTHESES (2012)
Metformin and the ATM DNA damage response (DDR): Accelerating the onset of stress-induced senescence to boost protection against cancer
Javier A. Menendez et al.
AGING-US (2011)
Sensing of energy and nutrients by AMP-activated protein kinase
D. Grahame Hardie
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Energy metabolism in nuclear reprogramming
Clifford D. L. Folmes et al.
BIOMARKERS IN MEDICINE (2011)
The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
Alejandro Vazquez-Martin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
Dimitrios Iliopoulos et al.
CANCER RESEARCH (2011)
The Lin28/let-7 Axis Regulates Glucose Metabolism
Hao Zhu et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Metformin activates an Ataxia Telangiectasia Mutated (ATM)/Chk2-regulated DNA damage-like response
Alejandro Vazquez-Martin et al.
CELL CYCLE (2011)
Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin Induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a
Cristina Oliveras-Ferraros et al.
CELL CYCLE (2011)
mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency A roadmap from energy metabolism to stem cell renewal and aging
Javier A. Menendez et al.
CELL CYCLE (2011)
Anaerobicizing into Pluripotency
Athanasia D. Panopoulos et al.
CELL METABOLISM (2011)
Somatic Oxidative Bioenergetics Transitions into Pluripotency-Dependent Glycolysis to Facilitate Nuclear Reprogramming
Clifford D. L. Folmes et al.
CELL METABOLISM (2011)
Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape
Bernadett Papp et al.
CELL RESEARCH (2011)
Inducing iPSCs to Escape the Dish
Bonnie Barrilleaux et al.
CELL STEM CELL (2011)
Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
Guilherme Z. Rocha et al.
CLINICAL CANCER RESEARCH (2011)
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
X. Stephenne et al.
DIABETOLOGIA (2011)
Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions
Alejandro Vazquez-Martin et al.
DRUG RESISTANCE UPDATES (2011)
Small RNA-mediated regulation of iPS cell generation
Zhonghan Li et al.
EMBO JOURNAL (2011)
AMP-activated protein kinase-an energy sensor that regulates all aspects of cell function
D. Grahame Hardie
GENES & DEVELOPMENT (2011)
Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53 TARGETING WARBURG EFFECT TO FIGHT CANCER
Joanna Zawacka-Pankau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Oncogene-Induced Senescence and its Role in Tumor Suppression
Jay P. Reddy et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2011)
Integrated Analysis of ATM Mediated Gene and Protein Expression Impacting Cellular Metabolism
Amrita K. Cheema et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1
Momoko Maekawa et al.
NATURE (2011)
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Maria M. Mihaylova et al.
NATURE CELL BIOLOGY (2011)
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
Peng Jiang et al.
NATURE CELL BIOLOGY (2011)
Energy Metabolism in Human Pluripotent Stem Cells and Their Differentiated Counterparts
Sandra Varum et al.
PLOS ONE (2011)
Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression
Ji-Won Jung et al.
PLOS ONE (2011)
Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs
Robert J. A. Frost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Metformin: Multi-faceted protection against cancer
Sonia Del Barco et al.
ONCOTARGET (2011)
Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor
Adriana S. Beltran et al.
BREAST CANCER RESEARCH (2011)
Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer
S. Fogarty et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Metformin and Other Biguanides in Oncology: Advancing the Research Agenda
Michael Pollak
CANCER PREVENTION RESEARCH (2010)
Rethinking the Warburg Effect with Myc Micromanaging Glutamine Metabolism
Chi V. Dang
CANCER RESEARCH (2010)
Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT) From cancer stem cells to aging-associated fibrosis
Silvia Cufi et al.
CELL CYCLE (2010)
Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
Alejandro Vazquez-Martin et al.
CELL CYCLE (2010)
Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
Simon A. Hawley et al.
CELL METABOLISM (2010)
Vitamin C Enhances the Generation of Mouse and Human Induced Pluripotent Stem Cells
Miguel Angel Esteban et al.
CELL STEM CELL (2010)
Metformin and Energy Metabolism in Breast Cancer: From Insulin Physiology to Tumour-initiating Stem Cells
A. Vazquez-Martin et al.
CURRENT MOLECULAR MEDICINE (2010)
Induced pluripotent stem cells and senescence: learning the biology to improve the technology
Ana Banito et al.
EMBO REPORTS (2010)
The role of let-7 in cell differentiation and cancer
Benjamin Boyerinas et al.
ENDOCRINE-RELATED CANCER (2010)
Metformin: Taking away the candy for cancer?
Mathilde Jalving et al.
EUROPEAN JOURNAL OF CANCER (2010)
AMPK as a metabolic tumor suppressor: control of metabolism and cell growth
Zhijun Luo et al.
FUTURE ONCOLOGY (2010)
Induced pluripotency: history, mechanisms, and applications
Matthias Stadtfeld et al.
GENES & DEVELOPMENT (2010)
Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells
Alessandro Prigione et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2010)
An energetic tale of AMPK-independent effects of metformin
Russell A. Miller et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Marc Foretz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Targeting Breast Cancer Stem Cells
Suling Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
p53 connects tumorigenesis and reprogramming to pluripotency
Natalia Tapia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
Issam Ben Sahra et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Opposing microRNA families regulate self-renewal in mouse embryonic stem cells
Collin Melton et al.
NATURE (2010)
Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies
Hao Zhu et al.
NATURE GENETICS (2010)
Lin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells
Caihong Qiu et al.
NUCLEIC ACIDS RESEARCH (2010)
Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer
S. Peng et al.
ONCOGENE (2010)
The Senescence-Related Mitochondrial/Oxidative Stress Pathway is Repressed in Human Induced Pluripotent Stem Cells
Alessandro Prigione et al.
STEM CELLS (2010)
SENESCENCE Senescence in tumours: evidence from mice and humans
Manuel Collado et al.
NATURE REVIEWS CANCER (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
AMP-activated protein kinase activator A-769662 is an inhibitor of the Na+-K+-ATPase
Boubacar Benziane et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Let-7 and miR-200 microRNAs Guardians against pluripotency and cancer progression
Marcus E. Peter
CELL CYCLE (2009)
AMPK Evidence for an energy-sensing cytokinetic tumor suppressor
Alejandro Vazquez-Martin et al.
CELL CYCLE (2009)
The role of p53 in limiting somatic cell reprogramming
Yan Liu et al.
CELL RESEARCH (2009)
Hypoxia Enhances the Generation of Induced Pluripotent Stem Cells
Yoshinori Yoshida et al.
CELL STEM CELL (2009)
Mouse Fibroblasts Lacking RB1 Function Form Spheres and Undergo Reprogramming to a Cancer Stem Cell Phenotype
Yongqing Liu et al.
CELL STEM CELL (2009)
Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins
Hongyan Zhou et al.
CELL STEM CELL (2009)
MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Chi V. Dang et al.
CLINICAL CANCER RESEARCH (2009)
Senescence impairs successful reprogramming to pluripotent stem cells
Ana Banito et al.
GENES & DEVELOPMENT (2009)
Tumor suppressors and cell metabolism: a recipe for cancer growth
Russell G. Jones et al.
GENES & DEVELOPMENT (2009)
Structural and Biochemical Studies of TIGAR (TP53-induced Glycolysis and Apoptosis Regulator)
Hua Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
STEM CELLS The promises and perils of p53
Valery Krizhanovsky et al.
NATURE (2009)
Linking the p53 tumour suppressor pathway to somatic cell reprogramming
Teruhisa Kawamura et al.
NATURE (2009)
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Rosa M. Marion et al.
NATURE (2009)
Direct cell reprogramming is a stochastic process amenable to acceleration
Jacob Hanna et al.
NATURE (2009)
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway
Hyenjong Hong et al.
NATURE (2009)
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
Jochen Utikal et al.
NATURE (2009)
The Ink4/Arf locus is a barrier for iPS cell reprogramming
Han Li et al.
NATURE (2009)
Lin28 promotes transformation and is associated with advanced human malignancies
Srinivas R. Viswanathan et al.
NATURE GENETICS (2009)
c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry
F. Morrish et al.
ONCOGENE (2009)
mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
David B. Shackelford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation
Eirini P. Papapetrou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Deconstructing Stem Cell Tumorigenicity: A Roadmap to Safe Regenerative Medicine
Paul S. Knoepfler
STEM CELLS (2009)
Embryonic Stem Cell MicroRNAs: Defining Factors in Induced Pluripotent (iPS) and Cancer (CSC) Stem Cells?
Preethi H. Gunaratne
CURRENT STEM CELL RESEARCH & THERAPY (2009)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
Xu Huang et al.
BIOCHEMICAL JOURNAL (2008)
Participation of OCT3/4 and β-catenin during dysgenetic gonadal malignant transformation
Icela Palma et al.
CANCER LETTERS (2008)
Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis
Tingsong Hu et al.
CANCER RESEARCH (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Why myc? An unexpected ingredient in the stem cell cocktail
Paul S. Knoepfler
CELL STEM CELL (2008)
Module map of stem cell genes guides creation of epithelial cancer stem cells
David J. Wong et al.
CELL STEM CELL (2008)
Guidelines and Techniques for the Generation of Induced Pluripotent Stem Cells
Nimet Maherali et al.
CELL STEM CELL (2008)
Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma
Shih-Hwa Chiou et al.
CLINICAL CANCER RESEARCH (2008)
Cellular life span and the Warburg effect
Hiroshi Kondoh
EXPERIMENTAL CELL RESEARCH (2008)
The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer
Yupeng Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy
Madhuri Kakarala et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Hongwu Zheng et al.
NATURE (2008)
Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds
Danwei Huangfu et al.
NATURE BIOTECHNOLOGY (2008)
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2
Danwei Huangfu et al.
NATURE BIOTECHNOLOGY (2008)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Keisuke Okita et al.
SCIENCE (2008)
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Masato Nakagawa et al.
NATURE BIOTECHNOLOGY (2008)
Induced pluripotent stem cell lines derived from human somatic cells
Junying Yu et al.
SCIENCE (2007)
Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase
Olga Goeransson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family
Matthew J. Sanders et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Cellular senescence in cancer and aging
Manuel Collado et al.
CELL (2007)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
Strategies and new developments in the generation of patient-specific pluripotent stem cells
Shinya Yamanaka
CELL STEM CELL (2007)
Generation of induced pluripotent stem cells in the absence of drug selection
Robert Blelloch et al.
CELL STEM CELL (2007)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
p53 regulates mitochondrial respiration
Satoaki Matoba et al.
SCIENCE (2006)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
Emerging role of KLF4 in human gastrointestinal cancer
DY Wei et al.
CARCINOGENESIS (2006)
Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues
K Hochedlinger et al.
CELL (2005)
Stem cells in mammary development and carcinogenesis - Implications for prevention and treatment
Gabriela Dontu et al.
STEM CELL REVIEWS (2005)
Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo -: Role of mitochondrial reactive nitrogen species (Publication with Expression of Concern. See vol. 294, pg. 10024, 2019) (Withdrawn Publication. See vol. 294, pg. 13525, 2019)
MH Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
JM Sperger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Stem cell pluripotency and transcription factor Oct4
GJ Pan et al.
CELL RESEARCH (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
MR Owen et al.
BIOCHEMICAL JOURNAL (2000)
分享论文
